February 7, 2022
With several large medical device companies expected to make acquisitions this year, along with valuations of prospective acquisition targets dropping, many industry analysts have noted that 2022 could be a big year for medical device and diagnostics M&A.
Based on management commentary during recent earnings calls, companies that are likely to be active in M&A this year include Johnson & Johnson, Hologic, Boston Scientific (although not to the extent it was in 2021), and possibly Abbott.
On Friday, Ryan Zimmerman, a medtech analyst at BTIG, pointed to seven medical device subsectors that could be attractive from an M&A perspective. In the following slides, we take a look at each of those spaces and offer our own educated guesses as to some of the players that could potentially be scooped up by a larger company this year.
About the Author(s)
You May Also Like